Loading organizations...
Biotechnology company focused on lupus treatment and novel biologics.
Resolve Therapeutics has raised $7.8M across 2 funding rounds.
Resolve Therapeutics has raised $7.8M in total across 2 funding rounds.
Resolve Therapeutics has raised $7.8M in total across 2 funding rounds.
Resolve Therapeutics's investors include Easton Capital, Thong Le, John Friedman.
Resolve Therapeutics has raised $7.8M across 2 funding rounds. Most recently, it raised $5.8M Series B in November 2012.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Nov 1, 2012 | $5.8M Series B | Easton Capital, Thong Le | |
| May 17, 2011 | $2.0M Series A | John Friedman |